WO1998041652A3 - Dna zum nachweis von veränderungen des chromosoms 7 - Google Patents

Dna zum nachweis von veränderungen des chromosoms 7 Download PDF

Info

Publication number
WO1998041652A3
WO1998041652A3 PCT/DE1998/000782 DE9800782W WO9841652A3 WO 1998041652 A3 WO1998041652 A3 WO 1998041652A3 DE 9800782 W DE9800782 W DE 9800782W WO 9841652 A3 WO9841652 A3 WO 9841652A3
Authority
WO
WIPO (PCT)
Prior art keywords
dna
chromosome
detecting changes
polypeptides
detecting
Prior art date
Application number
PCT/DE1998/000782
Other languages
English (en)
French (fr)
Other versions
WO1998041652A2 (de
Inventor
Peter Lichter
Konstanze Fischer
Hartmut Doehner
Original Assignee
Deutsches Krebsforsch
Peter Lichter
Konstanze Fischer
Hartmut Doehner
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Deutsches Krebsforsch, Peter Lichter, Konstanze Fischer, Hartmut Doehner filed Critical Deutsches Krebsforsch
Publication of WO1998041652A2 publication Critical patent/WO1998041652A2/de
Publication of WO1998041652A3 publication Critical patent/WO1998041652A3/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Die vorliegende Erfindung betrifft DNA zum Nachweis von Veränderungen des Chromosoms 7 und durch solche DNA kodierte Polypeptide. Ferner betrifft die Erfindung Antikörper, die gegen die Polypeptide gerichtet sind. Desweiteren betrifft sie die Verwendung der DNA und der Polypeptide sowie einen zum Nachweis einer Veränderung des Chromosoms 7 geeigneten Kit.
PCT/DE1998/000782 1997-03-15 1998-03-13 Dna zum nachweis von veränderungen des chromosoms 7 WO1998041652A2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19710926.8 1997-03-15
DE19710926A DE19710926C2 (de) 1997-03-15 1997-03-15 DNA zum Nachweis von Veränderungen des Chromosoms 7

Publications (2)

Publication Number Publication Date
WO1998041652A2 WO1998041652A2 (de) 1998-09-24
WO1998041652A3 true WO1998041652A3 (de) 1998-12-17

Family

ID=7823584

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/DE1998/000782 WO1998041652A2 (de) 1997-03-15 1998-03-13 Dna zum nachweis von veränderungen des chromosoms 7

Country Status (2)

Country Link
DE (1) DE19710926C2 (de)
WO (1) WO1998041652A2 (de)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997008339A1 (en) * 1995-08-25 1997-03-06 Dade International Inc. Chronic myelogenous leukemia diagnostic assay

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997008339A1 (en) * 1995-08-25 1997-03-06 Dade International Inc. Chronic myelogenous leukemia diagnostic assay

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
BEAU M ET AL: "Cytogenetic and molecular delineation of a region of chromosome 7 commonly deleted in malignant myeloid diseases", BLOOD, vol. 88, no. 6, 15 September 1996 (1996-09-15), pages 1930 - 5, XP002080798 *
EMBL Database Entry HSAC117 Accession number AC000117; 14 February 1997; Maggi, L. et al.;"Human BAC clone RG062A19 from 7q22; HTGS phase 3, complete sequence *
FISCHER K ET AL: "Molecular cytogenetic delineation of deletions and translocations involving chromosome band 7Q22 in myeloid leukemias", BLOOD, vol. 88, no. (10 Suppl. 1 part 1-2 ), 6 December 1996 (1996-12-06) - 10 December 1996 (1996-12-10), pages 65a, XP002080797 *
JOHNSON E ET AL: "Monosomy 7 and 7q- associated with myeloid malignancy", BLOOD REVIEWS, vol. 11, no. 1, March 1997 (1997-03-01), pages 46 - 55, XP002080799 *
LEWIS ET AL: "Molecular characterization of the 7Q deletion in myeloid disorders", BRITISH JOURNAL OF HAEMATOLOGY, vol. 93, no. 1, 1996, pages 74 - 80, XP002080800 *
OSCIER D ET AL: "Structural abnormalities of chromosome 7Q vin chronic lymphoproliferative disorders", CANCER GENETICS AND CYTOGENETICS, vol. 92, no. 1, November 1996 (1996-11-01), pages 24 - 27, XP002080801 *

Also Published As

Publication number Publication date
DE19710926A1 (de) 1998-09-17
DE19710926C2 (de) 1999-11-04
WO1998041652A2 (de) 1998-09-24

Similar Documents

Publication Publication Date Title
WO2000008057A3 (en) Molecules designated b7l-1
WO1996009386A3 (en) Allelic variation of the serotonin 5ht2c receptor
WO2000008158A3 (en) Molecules designated ldcam
AU1675900A (en) Complementary dna's encoding proteins with signal peptides
WO1999020747A3 (en) HUMAN CHECKPOINT KINASE, hCDS1, COMPOSITIONS AND METHODS
WO1998057983A3 (en) Mammalian neuro-growth factor like protein
CA2290582A1 (en) Rapid evaluation of the ratio of biological molecules
ZA9710163B (en) Novel carboxylesterase nucleic acid molecules, proteins and uses thereof.
WO2001064837A8 (en) β NETRIN AND USES THEREOF
NZ294019A (en) Proteins associated with the hippocampus; dna sequences coding therefor, antibodies to the proteins
WO2000020450A3 (en) Calcium channel alpha-2/delta gene
AU1137699A (en) Novel reovirus-derived proteins, nucleic acids encoding same, and uses therefor
EP0677115A4 (de) Tia-1 bindendes protein und dafür kodierende, isolierte und komplementäre dna.
WO1998041652A3 (de) Dna zum nachweis von veränderungen des chromosoms 7
CA2199403A1 (en) Novel PKA-Binding Proteins and Uses Thereof
AU1599299A (en) Methods and reagents for the utilization of sap family member proteins, novel signal transduction regulators
NO995948D0 (no) DNA-sekvenser, ekspresjon av disse DNA-sekvenser, termofile laccaser kodet for av DNA-sekvensene, samt anvendelse av disse
AU7753700A (en) Dna encoding prost 07 polypeptide
AU5137698A (en) Novel dna, novel protein, and novel antibody
CA2199843A1 (en) Novel PKA-Binding Proteins and Uses Thereof
AU6844596A (en) Nucleotide sequence encoding the cd33-like protein
WO2001025444A3 (en) Novel human phosphodiesterase zcytor13
AU4619297A (en) Ptx sensitive g proteins, the production and use thereof
ZA99445B (en) Isolated, polypeptides which bind to HLA-A29 molecules nucleic acid, the molecules encoding these, and uses thereof.
AU6679498A (en) A novel bak binding protein, dna encoding the protein, and methods of use thereof

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): JP US

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): JP US

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE

121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: JP

Ref document number: 1998540029

Format of ref document f/p: F

122 Ep: pct application non-entry in european phase